📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG. (2017)

First Author: Hadji P

Attributed to: Lifecourse Determinants of Bone and Joint Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jbo.2017.03.001

PubMed Identifier: 28413771

Publication URI: http://europepmc.org/abstract/MED/28413771

Type: Journal Article/Review

Volume: 7

Parent Publication: Journal of bone oncology

ISSN: 2212-1366